Literature DB >> 21735686

[Increased oxidized LDL cholesterol levels in peritoneal fluid of women with advanced-stage endometriosis].

Grzegorz Polak1, Diana Mazurek, Ewelina Rogala, Aldona Nowicka, Magdalena Derewianka-Polak, Jan Kotarski.   

Abstract

INTRODUCTION: Proinflammatory and prooxidative environment in the peritoneal cavity may be involved in the pathogenesis of endometriosis. Imbalance between reactive oxygen species levels and the antioxidant capacity leads to oxidation of low-density lipoproteins (LDL). The importance of oxidized LDL (Ox-LDL) in the development of atherosclerosis is well recognized. AIM: The aim of our study was to evaluate for the presence of ox-LDL in the peritoneal fluid (PF) of women with and without endometriosis.
MATERIAL AND METHODS: A total of 60 women who underwent laparoscopy were divided into groups: endometriosis sufferers with minimal to mild (n 20) and moderate to severe (n 20) stages, and the reference group (n 20) with functional follicle ovarian cysts. Oxidized LDL levels were determined in the PF using enzyme immunoassay
RESULTS: Oxidized LDL levels were detectable in all peritoneal fluid samples. Significantly increased levels of ox-LDL were observed in PF of women with stage III/IV endometriosis compared to the reference group (p = 0.03). However peritoneal fluid ox-LDL concentrations did not differ significantly between patients with minimal/mild and women with moderate/severe stage of the disease (p = 0.2). No significant difference in the PF ox-LDL concentrations was also found between women with stage I/II endometriosis and patients with follicle cysts (p = 0.3).
CONCLUSIONS: Increased peritoneal fluid ox-LDL levels observed in women with advanced-stage endometriosis suggest the important role of oxidative stress in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735686

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  6 in total

1.  Assessment of pain and stress intensity among women with ovarian endometriomas versus teratomas.

Authors:  Karolina Stella Chmaj-Wierzchowska; Małgorzata Kampioni; Maciej Wilczak; Stefan Sajdak; Tomasz Opala
Journal:  Pain Res Manag       Date:  2015 May-Jun       Impact factor: 3.037

2.  The 763C>G Polymorphism of The Secretory PLA2IIa Gene Is Associated with Endometriosis in Iranian Women.

Authors:  Mehdi Sahmani; Masoud Darabi; Maryam Darabi; Talaat Dabaghi; Safar Ali Alizadeh; Reza Najafipour
Journal:  Int J Fertil Steril       Date:  2015-02-07

3.  Hidrox® and Endometriosis: Biochemical Evaluation of Oxidative Stress and Pain.

Authors:  Marika Cordaro; Angela Trovato Salinaro; Rosalba Siracusa; Ramona D'Amico; Daniela Impellizzeri; Maria Scuto; Maria Laura Ontario; Livia Interdonato; Roberto Crea; Roberta Fusco; Salvatore Cuzzocrea; Rosanna Di Paola; Vittorio Calabrese
Journal:  Antioxidants (Basel)       Date:  2021-05-04

4.  Low-density lipoproteins oxidation and endometriosis.

Authors:  Grzegorz Polak; Bartłomiej Barczyński; Wojciech Kwaśniewski; Wiesława Bednarek; Iwona Wertel; Magdalena Derewianka-Polak; Jan Kotarski
Journal:  Mediators Inflamm       Date:  2013-06-19       Impact factor: 4.711

5.  The Root Aqueous Extract of Entada africana Guill. et Perr. (Mimosaceae) Inhibits Implant Growth, Alleviates Dysmenorrhea, and Restores Ovarian Dynamic in a Rat Model of Endometriosis.

Authors:  Marie Alfrede Mvondo; Stéphane Minko Essono; Francis Désiré Bomba Tatsinkou; Sylvin Benjamin Ateba; Dieudonné Njamen
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

Review 6.  An Overview on the Conservative Management of Endometriosis from a Naturopathic Perspective: Phytochemicals and Medicinal Plants.

Authors:  Andreea Balan; Marius Alexandru Moga; Lorena Dima; Catalina Georgeta Dinu; Carmen Constantina Martinescu; Diana Elena Panait; Claudia Alexandrina Irimie; Costin Vlad Anastasiu
Journal:  Plants (Basel)       Date:  2021-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.